Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | PDE6D | O43924 | 1/20 | 0.33 |
| ▸ | PRKDC | P78527 | 1/20 | 0.32 |
| ▸ | EDNRB | P24530 | 1/20 | 0.32 |
| ▸ | EDNRA | P25101 | 1/20 | 0.32 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17038455 | 0.97 | KDM4E (0.39) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL24677422 | 0.93 | L3MBTL1 (0.41) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL17038425 | 0.92 | L3MBTL1 (0.45) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL17038426 | 0.91 | L3MBTL1 (0.41) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL23072418 | 0.91 | ATM (0.39) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL24677556 | 0.89 | KDM4E (0.40) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL17038418 | 0.89 | L3MBTL1 (0.44) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL17038454 | 0.88 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL17057179 | 0.88 | ALOX5 (0.36) | KDM4EATML3MBTL1LIMK1ALOX5 | |
| SCHEMBL17038424 | 0.88 | ATM (0.41) | KDM4EATML3MBTL1LIMK1ALOX5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10707423-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-07-07 | — | — | US | disclosed |
| US-20150243894-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-08-27 | — | — | US | disclosed |
| US-20150243894-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10707423-B2 | Organic electroluminescent materials and devices | OCIAD1, OXA1L, SLCO2B1 | KDM4E 3237/4885ATM 3925/4885L3MBTL1 517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.